Status:
UNKNOWN
Prevention of Cancer-associated Malnutrition Through Oral Nutritional Supplements
Lead Sponsor:
University of Hohenheim
Collaborating Sponsors:
University Hospital Tuebingen
Conditions:
Cancer
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The aim of the randomized controlled study is to determine effects of an adjusted amount of oral nutritional supplements on the quality of life, the nutritional status, side effects, and response to t...
Detailed Description
Cancer is often associated with malnutrition and weight loss. The occurence of malnutrition during the course of the disease depends on the type, extent, and therapy of the tumor. Pancreatic cancer pa...
Eligibility Criteria
Inclusion
- assured diagnosis of pancreatic cancer/hepatocellular carcinoma, not treatable with curative intent
- palliative systemic therapy of pancreatic cancer respectively palliative therapy of hepatocellular carcinoma with Sorafenib or TACE (transarterial chemoembolization)
- written informed consent prior to inclusion
Exclusion
- prefinal phase with an estimated life expectancy of less than three months
- nutritional support through tube feeding or a central venous catheter
- serious malassimilation (assessed by anamnesis)
- Eastern Cooperative Oncology Group (ECOG) Performance Status ≥ 2
- hepatic encephalopathy ≥ degree 2
Key Trial Info
Start Date :
January 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2016
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT02312674
Start Date
January 1 2015
End Date
January 1 2016
Last Update
December 9 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.